SCHEMBL11427078

SCHEMBL11427078

O=C(NCCn1ccnc1)Nc1ccccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.56
▸ HTT P42858 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ ALOX15 P16050 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ LMNA P02545 2/20 0.48
▸ MAPT P10636 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ QPCT Q16769 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11388731 0.81 TBXAS1 (0.62) SMN1; SMN2HTTL3MBTL1KDM4E
SCHEMBL27285135 0.78 NPC1 (0.60) SMN1; SMN2CYP1A2CYP3A4CYP2D6MEN1
SCHEMBL13503153 0.77 CYP1A2 (0.67) SMN1; SMN2HTTL3MBTL1KDM4ECYP1A2
SCHEMBL1775043 0.75 CYP1A2 (0.79) SMN1; SMN2HTTL3MBTL1KDM4ECYP1A2
SCHEMBL3816499 0.75 SMN1; SMN2 (0.68) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL10985519 0.75 SMN1; SMN2 (0.83) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL5050746 0.75 SMN1; SMN2 (0.68) SMN1; SMN2HTTALDH1A1MEN1KMT2A
SCHEMBL30499260 0.74 HTT (0.60) SMN1; SMN2HTTKDM4EALDH1A1MEN1
SCHEMBL10833281 0.74 ALDH1A1 (0.87) SMN1; SMN2HTTL3MBTL1CYP1A2CYP3A4
SCHEMBL10833432 0.74 L3MBTL1 (0.72) SMN1; SMN2L3MBTL1KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4273782-A FOR USE IN CARDIOVASCULAR DISORDERS AND COMPLICATIONS OF DIABETES PFIZER INC. (US) 1981-06-16 — — US disclosed
Send feedback